Literature DB >> 15178888

Quantitative analysis of mast cells in benign and malignant breast lesions. Immunohistochemical study on formalin-fixed, paraffin-embedded tissues.

Yayoi Kashiwase1, Junichiro Morioka, Hiroaki Inamura, Yoshitomo Yoshizawa, Ryu Usui, Motohiro Kurosawa.   

Abstract

BACKGROUND: It has been reported that the number of mast cells was significantly greater in malignant breast carcinomas than in benign breast lesions. This was due to tryptase-containing mast cells while tryptase, chymase-containing mast cells had no effect. However, analysis of mast cells in breast carcinomas and benign breast lesions based on their histological findings remains to be elucidated.
METHODS: Using immunohistochemical methods morphological examinations of mast cells were undertaken in benign and malignant breast tissues from 51 patients (30 benign, 21 malignant), which were formalin-fixed and paraffin-embedded. In the study with malignant breast tissues, samples of malignant tissues and adjacent healthy tissues were obtained from a single patient, and the number of mast cells was compared.
RESULTS: Among benign breast tissues, the number of mast cells in intracanalicular fibroadenoma was significantly lower than that in pericanalicular fibroadenoma as well as that in mastopathy. The number of mast cells was significantly greater in malignant lesions than that in benign lesions. The number of mast cells in scirrhous carcinoma and that in solid-tubular carcinoma were significantly increased compared with that in adjacent healthy tissues. In addition, the number of mast cells in scirrhous carcinoma was highest among breast carcinomas, and significantly greater than that in papillotubular carcinoma.
CONCLUSION: We were the first to find the significant lower number of mast cells in intracanalicular breast fibroadenoma when compared with that in pericanalicular fibroadenoma as well as that in mastopathy. Moreover, the number of mast cells in scirrhous carcinoma was significantly greater than that in papillotubular carcinoma. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15178888     DOI: 10.1159/000078766

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  6 in total

1.  Tryptase-positive mast cells and angiogenesis in keloids: a new possible post-surgical target for prevention.

Authors:  Michele Ammendola; Valeria Zuccalà; Rosa Patruno; Emilio Russo; Maria Luposella; Andrea Amorosi; Giuseppina Vescio; Giuseppe Sammarco; Severino Montemurro; Giovambattista De Sarro; Rosario Sacco; Girolamo Ranieri
Journal:  Updates Surg       Date:  2012-11-02

2.  Conjugated linoleic acid induces mast cell recruitment during mouse mammary gland stromal remodeling.

Authors:  Joshua S Russell; Sibel Oflazoglu McGee; Margot M Ip; Dietrich Kuhlmann; Patricia A Masso-Welch
Journal:  J Nutr       Date:  2007-05       Impact factor: 4.798

3.  Mast Cell Tryptase Contributes to Pancreatic Cancer Growth through Promoting Angiogenesis via Activation of Angiopoietin-1.

Authors:  Xiangjie Guo; Liqin Zhai; Ruobing Xue; Jieru Shi; Qiang Zeng; Cairong Gao
Journal:  Int J Mol Sci       Date:  2016-05-27       Impact factor: 5.923

4.  The associations between mast cell infiltration, clinical features and molecular types of invasive breast cancer.

Authors:  Jianfeng Sang; Dandan Yi; Xiaoqiao Tang; Yifen Zhang; Tao Huang
Journal:  Oncotarget       Date:  2016-12-06

5.  An In Vitro Model of Mast Cell Recruitment and Activation by Breast Cancer Cells Supports Anti-Tumoral Responses.

Authors:  Angélica Aponte-López; Jennifer Enciso; Samira Muñoz-Cruz; Ezequiel M Fuentes-Pananá
Journal:  Int J Mol Sci       Date:  2020-07-26       Impact factor: 5.923

6.  Lack of c-kit receptor promotes mammary tumors in N-nitrosomethylurea-treated Ws/Ws rats.

Authors:  Maricel V Maffini; Ana M Soto; Carlos Sonnenschein; Nikoletta Papadopoulos; Theoharis C Theoharides
Journal:  Cancer Cell Int       Date:  2008-04-29       Impact factor: 5.722

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.